This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Oxytocin Market

Market Insights on Oxytocin covering sales outlook, demand forecast & up-to-date key trends

Oxytocin Market By Product (Antepartum and Postpartum), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores and Online Pharmacies) & Region - Forecast 2022 - 2030

Oxytocin Market Snapshot (2022-2030)

[265 Pages Report] Global Oxytocin market are set to experience a significant growth of 9.0% CAGR from 2022 to 2030, with an estimated market value of around US$ 83.0 Mn as of 2022. As per Future Market Insights’ projections, Postpartum type holds a substantial share of over 88.8%  in 2021 within the Global market.

Data Points

Market Insights

Market Value 2021

US$ 76.0 Mn

Market Value 2022

US$ 83.0 Mn

Market Value 2030

US$ 164.9 Mn

CAGR 2022-2030

9.0%

Market Share of Top 5 Countries

51.2%

Key Market Players

Pfizer Inc., Novartis AG, Ferring B.V., Fresenius Kabi LLC, Hikma Pharmaceuticals PLC, Endo International plc. (Par Sterile Products, LLC), Teva Pharmaceutical Industries Ltd., Mylan N.V., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., and Yuhan Corporation

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

8.41%

H1, 2022 Projected

8.96%

H1, 2022 Outlook

8.96%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(+) 45 ↑

As compared to H1-2021, the oxytocin market is expected to surge by 45 basis point share (BPS) in H1-2022 (O), according to FMI. However, comparison analysis for the H1-2022 projected and H1-2022 outlook period reflected a decline in growth rate by nearly 10 BPS.

The use of high-quality injectable oxytocin to effectively prevent and treat postpartum haemorrhage, the main cause of maternal death worldwide, is one of the key reasons contributing to the rise in BPS.

FMI provides a comparative study of the global oxytocin market's growth rates and development prospects. Market authorization and regulatory approvals, as well as the impact of macro and industrial factors, have an impact on the market. The introduction of FDA-approved exogenous oxytocin in the antepartum phase for enhancing uterine contractions with the goal of a successful vaginal birth of the foetus is a key development in this sector.

The thermal sensitivity of oxytocin, which can result in its quality being deteriorated at several points along the health supply chain, including at the manufacturing site owing to low quality of API, a dearth of sterile production systems, or poor production methods, and during storage and transport caused by a lack of temperature regulation in the distribution network, including co-packaging, can conversely provide a restrictive growth impact on the oxytocin market.

Sales Analysis of Oxytocin from 2015 to 2021 Vs Market Outlook for 2022 to 2030

The Oxytocin market holds nearly 6.3% of the overall US$ 1.2 Bn Growth Hormones market in 2021.

The market of oxytocin on a global scale is considered extremely fragmented, with numerous local and multinational players active. Most products purchased from local players are provided by the National Government Procurement Agencies to the local governments. Thus, several developing countries are dependent upon local players, leading to an increase in focus on procurement of high volumes for lower costs. 

The global oxytocin market includes an increase in the licensing activities of companies to develop new therapeutics for a range of indications.

The global oxytocin industry is set to be driven by factors including the rapidly growing global birth rate as well as the raised complications associated with birth. The overuse of caesarean delivery is expected to grow in the future which can create an unmet need of oxytocin treatment in the market. The pregnancy awareness programs offered by the local governments, NGOs and regulatory bodies are further expected to increase the awareness about the pregnancy care and healthcare setup based birth in the developing regions. The increasing awareness about pregnancy and the complications associated with it are thus the factors likely to ascend the boost in sales of oxytocin based products, thus increasing the market share growth of the oxytocin industry.

Rising demand for healthcare setup based pregnancy births and developments of high quality oxytocin therapeutics are re-shaping the therapeutic landscape in haemorrhage treatment in pregnancy. The current trend of “postpartum haemorrhage prevention” strategy is more suitable for reasons of medical need, efficacy, or desirability—has emerged as an accepted and valuable alternative to haemorrhage treatment, thus swiftly affecting the rise in oxytocin industry value.

Oxytocin Market Download Report Brochure

Moreover, leading healthcare organizations at national, regional and global level are recommending the use of oxytocin as prophylactic first-line treatment for the prevention and treatment of pregnancy and birth associated haemorrhage cases globally. 

The market is expected to expand at a considerable growth rate over the next eight years at a CAGR of close to 9.0%, and offer an absolute $ opportunity of US$ 7.7 Mn from 2021-2022. The above mentioned factors compile the sales outlook of the global oxytocin market, and are expected to raise value in the overall healthcare industry.

What are the New Opportunities for Oxytocin Producers?

Increasing healthcare expenditure and per capita income offers unique opportunity for leading oxytocin manufacturers to expand their presence in the emerging market such as Africa, China and India market.

Emerging scientific and technological advancements offers potential opportunities to expand the oxytocin indication to emerging applications such as pregnancy complication, autism, social anxiety and many others. These new indications are in development phases or being preferred to use off-label but in future they could offer potential growth opportunities.

Oxytocin therapeutic with incremental innovation such as high stability of formulation, development of new convenient dosage forms, high efficacy and potency versions are expected to provide potential opportunities for the leading companies in the global oxytocin market.

Most of the market opportunities in the global oxytocin market are present in developing region with complex nature of the market. In addition, the market is highly competitive and majorly operates by local players. Hence, the collaborative approach and partnership will offer high market penetration and growth opportunities.

What are the Factors Restraining Demand for Oxytocin?

The availability of alternate drugs like misoprostol and magnesium sulphate for labour induction or PPH treatment could hamper the growth of oxytocin market. Moreover, misoprostol available in tablet form unlike oxytocin which is in injection form, making product more stable and easily accessible for resource-poor countries.

Manufacturers in many countries are not obtaining WHO prequalification for manufacturing of oxytocin products. This leads to production of substandard quality of drugs in the market, thus, hampering its growth.

The current market structure where large number of manufacturers are creating high price-sensitive market. That makes this market less adherent to the required regulation owing to the cost involved in the upgradation of the manufacturing facilities.

Oxytocin has been used in the dairy farming sector to enhance lactation, to speed up the ripening of fruits and vegetables. The misuse of the drug can cause deterioration of milch cattle.

The increasing complaints and misuse of the oxytocin drugs resulted in a Government implied ban on all private sector companies for manufacturing and distributing oxytocin for domestic use in India without registration and cGMP practices.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-wise Insights

What Makes the U.S. the Largest Market for Oxytocin?

The U.S. dominates the North American region with a total market share of about 91.5% in 2021, and is projected to continue experiencing high growth throughout the forecast period. The growth of this market is driven by increasing awareness regarding pregnancy products and increasing expenditure on personal care products within the country. The rising responsiveness has resulted in successful pregnancy-related awareness programs and maternal and child health has inducted itself as an essential element of the U.S. healthcare system.

Why is Germany Considered a Lucrative Market for Oxytocin in Europe?

Germany is set to exhibit a CAGR of about 6.6% in the European Oxytocin market during the forecast period. The country has essentially incorporated advanced maternity care, resulting in proliferation of sales in the European region for oxytocin products. Presence of large industry players with key research impact upon the overall market structure, such as Novartis, in the region is further expected to present Germany as a lucrative research, development and production hub for oxytocin products in the European region throughout the forecast period.

What Makes China an Emerging Market for Oxytocin?

China holds 67.3% share in the East Asia market in 2021, and is projected to increase at a CAGR rate of 6.2% during the forecast period. The growth of the Oxytocin market in the country is attributed to the rising wave of automation and robotic assistive devices in the region of East Asia, with China as the prime contributor in the development industry for robotic devices for various intended uses, including Oxytocin for orthopaedic procedures. As a global manufacturing hub, China is likely to pose an increasing demand trend over the forecast period.

What is the Outlook for Japan Regarding Oxytocin?

In 2021, Japan held a 26.0% share in the East Asia Oxytocin market, and is projected to expand at a CAGR of 6.9% from 2022 to 2030. The rising research interest in Japan for novel therapeutics and hormonal therapy have promoted the region of East Asia as upcoming in terms of generating spurred revenues globally.

Category-wise Insights

Which Oxytocin Product is Driving Market Growth?

Postpartum product types project a lucrative growth at a CAGR of 8.7% till the end of the forecast period, with a market share of over 88.8% in 2021. The applications and use of postpartum oxytocin products has resulted in the decrease of post-partum haemorrhage, and thus is being gradually adopted over the globe with a collective gain of lowered maternal mortality.

Which Distribution Channel Holds a Dominant Stance in the Global Oxytocin Market?

Hospital Pharmacies hold a revenue share of 63.8% in 2021 and are projected to hold a share over the forecast period with the estimation being 87.0%. A majority of procedures involving the use of Oxytocin are performed within the hospitals. Moreover, hospital networks promote the purchasing power for Oxytocin market and are thus dominant as a Distribution Channel segment.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Competitive Landscape

The leading global oxytocin market players are focusing on research and development of innovative products with competitive advantages. The oxytocin market is a highly fragmented with a large number of local and multinational players operating in the market worldwide. The majority of the products in oxytocin market are procured from the local players by the national procurement agencies of the local governments.

  • In May 2020, Swissmedic Approved Carbetocin Ferring, heat-stable formulation of carbetocin for the Prevention of Postpartum Haemorrhage in All Births. It is the first medicine approved under the new Swissmedic and Marketing Authorisation for Global Health Products (MAGHP) procedure.
  • In 2021, A partner of Hikma, Vectura Group plc recently announced it has signed an agreement with Monash University’s Institute of Pharmaceutical Sciences (MIPS) to develop inhaled oxytocin delivered via a dry powder inhaler to prevent postpartum haemorrhage (PPH) in childbirth.

Similarly, recent developments related to companies manufacturing Oxytocin products have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as per Oxytocin Industry Analysis

Attribute

Details

Forecast Period

2022-2030

Historical Data Available for

2015-2021

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa

Key Countries Covered

US, Canada,  Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Malaysia, Indonesia, Thailand, Australia,New Zealand, GCC Countries, Turkey, Egypt, Nigeria, Algeria, Morocco, Kenya

Key Market Segments Covered

Product Distribution Channel and Region

Key Companies Profiled

  • Pfizer Inc.
  • Novartis AG
  • Ferring B.V.
  • Fresenius Kabi LLC
  • Hikma Pharmaceuticals PLC
  • Endo International plc. (Par Sterile Products, LLC)
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Wockhardt Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Yuhan Corporation

Pricing

Available upon Request

Key Market Segments Covered in Oxytocin Industry Research

By Product:

  • Antepartum
  • Postpartum

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global Oxytocin market is worth US$ 76.0 Mn at present, and is set to expand 2X over the next eight years.

The Oxytocin market is expected to reach US$ 164.9 Mn by the end of 2030, with sales revenue expected to register 9.0% CAGR.

Highly fragmented market, increased licensing activities and WHO prequalification are some of the key trends being witnessed in this marketplace.

The China, U. S., India, Canada and Japan are expected to drive demand for Oxytocin products.

North America is one of the key markets for Oxytocin, with the U.S. expected to account over 90.8% of the North American market revenue share during the forecast period.

Demand for Oxytocin in Europe is expected to register growth of 9.2% over the next seven years.

The U.S., India and Canada are key producers of Oxytocin products.

Pfizer Inc., Novartis AG, Ferring B.V., Fresenius Kabi LLC, Hikma Pharmaceuticals PLC, Endo International plc. (Par Sterile Products, LLC), Teva Pharmaceutical Industries Ltd., Mylan N.V., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., and Yuhan Corporation are the key exporters of Oxytocin market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market 

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption / Usage Analysis

    4.2. Strategic Promotional Strategies

    4.3. Regulatory Scenario

    4.4. Disease Epidemiology  

5. Global Oxytocin Market - Pricing Analysis

    5.1. Regional Pricing Analysis By Indication

    5.2. Pricing Break-up

        5.2.1. Manufacturer Level Pricing

        5.2.2. Distributor Level Pricing

    5.3. Global Average Pricing Analysis Benchmark

6. Global Oxytocin Market Demand (in Volume) Analysis 2015-2021 and Forecast, 2022-2030

    6.1. Historical Market Volume (Units Mn) Analysis, 2015-2021

    6.2. Current and Future Market Volume (Units Mn) Projections, 2022-2030

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Oxytocin Market Demand (in Value or Size in US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Market Background

    8.1. Macro-Economic Factors

        8.1.1. Global GDP Growth Outlook

        8.1.2. Global Healthcare Expenditure Outlook

    8.2. Forecast Factors - Relevance & Impact

        8.2.1. Increasing Prevalence of Pregnancy Complications

        8.2.2. Rising number of Birth Globally

        8.2.3. Growing Awareness of Induced Labour and Breastfeeding

    8.3. Value Chain

    8.4. Market Dynamics

        8.4.1. Drivers

        8.4.2. Restraints

        8.4.3. Opportunity Analysis

9. COVID19 Crisis Analysis

    9.1. Current COVID19 Statistics and Probable Future Impact

    9.2. Current GDP Projection and Probable Impact

    9.3. Current Economic Projection as compared to 2008 financial analysis

    9.4. COVID19 and Impact Analysis

        9.4.1. Revenue By Product

        9.4.2. Revenue By Country

    9.5. 2020 Market Scenario

    9.6. Quarter by Quarter Forecast

    9.7. Projected recovery Quarter

    9.8. Recovery Scenario – Short term, Midterm and Long Term Impact

10. Global Oxytocin Market Analysis 2015-2021 and Forecast 2022-2030, by Indication 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015 - 2021

    10.3. Current and Future Market Size (US$ Mn) and Forecast By Indication, 2022 - 2030

        10.3.1. Antepartum

        10.3.2. Postpartum

    10.4. Market Attractiveness Analysis By Indication 

11. Global Oxytocin Market Analysis 2015-2021 and Forecast 2022-2030, by Distribution Channel 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2015 - 2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2030

        11.3.1. Hospital Pharmacies

        11.3.2. Drug Stores

        11.3.3. Online Pharmacies

    11.4. Market Attractiveness Analysis By Distribution Channel

12. Global Oxytocin Market Analysis 2015-2021 and Forecast 2022-2030, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis by Region, 2015 - 2021

    12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2022 - 2030

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. Middle East and Africa (MEA)

        12.3.5. East Asia

        12.3.6. South Asia

        12.3.7. Oceania

    12.4. Market Attractiveness Analysis by Region

13. North America Oxytocin Market Analysis 2015-2021 and Forecast 2022-2030

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2021

    13.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030

        13.4.1.  By Country

            13.4.1.1. U.S.

            13.4.1.2. Canada

        13.4.2. By Indication

        13.4.3. By Distribution Channel

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Indication

        13.5.3. By Distribution Channel

    13.6. Market Trends

    13.7. Key Market Participants - Intensity Mapping

    13.8. Drivers and Restraints - Impact Analysis

14. Latin America Oxytocin Market 2015-2021 and Forecast 2022-2030

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2021

    14.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030

        14.4.1.  By Country

            14.4.1.1. Brazil

            14.4.1.2. Mexico

            14.4.1.3. Argentina

            14.4.1.4. Rest of Latin America

        14.4.2. By Indication

        14.4.3. By Distribution Channel

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Indication

        14.5.3. By Distribution Channel

    14.6. Market Trends

    14.7. Key Market Participants - Intensity Mapping

    14.8. Drivers and Restraints - Impact Analysis

15. Europe Oxytocin Market 2015-2021 and Forecast 2022-2030

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2021

    15.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030

        15.4.1.  By Country

            15.4.1.1. Germany

            15.4.1.2. Italy

            15.4.1.3. France

            15.4.1.4. U.K.

            15.4.1.5. Spain

            15.4.1.6. BENELUX

            15.4.1.7. Russia

            15.4.1.8. Rest of Europe

        15.4.2. By Indication

        15.4.3. By Distribution Channel

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Indication

        15.5.3. By Distribution Channel

    15.6. Market Trends

    15.7. Key Market Participants - Intensity Mapping

    15.8. Drivers and Restraints - Impact Analysis

16. South Asia Oxytocin Market 2015-2021 and Forecast 2022-2030

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2021

    16.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030

        16.4.1.  By Country

            16.4.1.1. India

            16.4.1.2. Thailand

            16.4.1.3. Indonesia

            16.4.1.4. Malaysia

            16.4.1.5. Rest of South Asia

        16.4.2. By Indication

        16.4.3. By Distribution Channel

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Indication

        16.5.3. By Distribution Channel

    16.6. Market Trends

    16.7. Key Market Participants - Intensity Mapping

    16.8. Drivers and Restraints - Impact Analysis

17. East Asia Oxytocin Market 2015-2021 and Forecast 2022-2030

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2021

    17.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030

        17.4.1.  By Country

            17.4.1.1. China

            17.4.1.2. Japan

            17.4.1.3. South Korea

        17.4.2. By Indication

        17.4.3. By Distribution Channel

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Indication

        17.5.3. By Distribution Channel

    17.6. Market Trends

    17.7. Key Market Participants - Intensity Mapping

    17.8. Drivers and Restraints - Impact Analysis

18. Oceania Oxytocin Market 2015-2021 and Forecast 2022-2030

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2021

    18.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030

        18.4.1.  By Country

            18.4.1.1. Australia

            18.4.1.2. New Zealand

        18.4.2. By Indication

        18.4.3. By Distribution Channel

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Indication

        18.5.3. By Distribution Channel

    18.6. Market Trends

    18.7. Key Market Participants - Intensity Mapping

    18.8. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Oxytocin Market 2015-2021 and Forecast 2022-2030

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2021

    19.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030

        19.4.1.  By Country

            19.4.1.1. GCC Countries

            19.4.1.2. South Africa

            19.4.1.3. Egypt

            19.4.1.4. Nigeria

            19.4.1.5. Algeria

            19.4.1.6. Morocco

            19.4.1.7. Kenya

            19.4.1.8. Rest of Middle East and Africa

        19.4.2. By Indication

        19.4.3. By Distribution Channel

    19.5. Market Attractiveness Analysis

        19.5.1. By Country

        19.5.2. By Indication

        19.5.3. By Distribution Channel

    19.6. Market Trends

    19.7. Key Market Participants - Intensity Mapping

    19.8. Drivers and Restraints - Impact Analysis

20. Emerging & Key Countries Oxytocin Market Analysis 

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. U.S. Oxytocin Market Analysis

        20.2.1. By Indication

        20.2.2. By Distribution Channel

    20.3. Canada Oxytocin Market Analysis

        20.3.1. By Indication

        20.3.2. By Distribution Channel

    20.4. Mexico Oxytocin Market Analysis

        20.4.1. By Indication

        20.4.2. By Distribution Channel

    20.5. Brazil Oxytocin Market Analysis

        20.5.1. By Indication

        20.5.2. By Distribution Channel

    20.6. Argentina Oxytocin Market Analysis

        20.6.1. By Indication

        20.6.2. By Distribution Channel

    20.7. Germany Oxytocin Market Analysis

        20.7.1. By Indication

        20.7.2. By Distribution Channel

    20.8. Italy Oxytocin Market Analysis

        20.8.1. By Indication

        20.8.2. By Distribution Channel

    20.9. France Oxytocin Market Analysis

        20.9.1. By Indication

        20.9.2. By Distribution Channel

    20.10. U.K. Oxytocin Market Analysis

        20.10.1. By Indication

        20.10.2. By Distribution Channel

    20.11. Spain Oxytocin Market Analysis

        20.11.1. By Indication

        20.11.2. By Distribution Channel

    20.12. Russia Oxytocin Market Analysis

        20.12.1. By Indication

        20.12.2. By Distribution Channel

    20.13. China Oxytocin Market Analysis

        20.13.1. By Indication

        20.13.2. By Distribution Channel

    20.14. Japan Oxytocin Market Analysis

        20.14.1. By Indication

        20.14.2. By Distribution Channel

    20.15. S. Korea Oxytocin Market Analysis

        20.15.1. By Indication

        20.15.2. By Distribution Channel

    20.16. India Oxytocin Market Analysis

        20.16.1. By Indication

        20.16.2. By Distribution Channel

    20.17. Malaysia Oxytocin Market Analysis

        20.17.1. By Indication

        20.17.2. By Distribution Channel

    20.18. Thailand Oxytocin Market Analysis

        20.18.1. By Indication

        20.18.2. By Distribution Channel

    20.19. Indonesia Oxytocin Market Analysis

        20.19.1. By Indication

        20.19.2. By Distribution Channel

    20.20. Australia Oxytocin Market Analysis

        20.20.1. By Indication

        20.20.2. By Distribution Channel

    20.21. New Zealand Oxytocin Market Analysis

        20.21.1. By Indication

        20.21.2. By Distribution Channel

    20.22. GCC Countries Oxytocin Market Analysis

        20.22.1. By Indication

        20.22.2. By Distribution Channel

    20.23. Turkey Oxytocin Market Analysis

        20.23.1. By Indication

        20.23.2. By Distribution Channel

    20.24. South Africa Oxytocin Market Analysis

        20.24.1. By Indication

        20.24.2. By Distribution Channel

    20.25. Egypt Oxytocin Market Analysis

        20.25.1. By Indication

        20.25.2. By Distribution Channel

    20.26. Nigeria Oxytocin Market Analysis

        20.26.1. By Indication

        20.26.2. By Distribution Channel

    20.27. Algeria Oxytocin Market Analysis

        20.27.1. By Indication

        20.27.2. By Distribution Channel

    20.28. Morroco Oxytocin Market Analysis

        20.28.1. By Indication

        20.28.2. By Distribution Channel

    20.29. Kenya Oxytocin Market Analysis

        20.29.1. By Indication

        20.29.2. By Distribution Channel

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies 

    21.2. Market Concentration

    21.3. Market Share Analysis of Top Players

    21.4. Market Presence Analysis

        21.4.1. By Regional Footprint of Players

        21.4.2. Product Footprint by Players

        21.4.3. Channel Footprint by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Pricing Analysis by Competition

    22.3. Competition Benchmarking

    22.4. Competition Deep Dive 

    22.5. Key Players Based On Estimated Tracked Revenue 

        22.5.1. Pfizer Inc.

            22.5.1.1. Indication Portfolio

            22.5.1.2. Profitability by Market Segments (Channel/Region)

            22.5.1.3. Sales Footprint

            22.5.1.4. Analyst commentary

            22.5.1.5. Strategy Overview

                22.5.1.5.1. Marketing Strategy

                22.5.1.5.2. Product Strategy

                22.5.1.5.3. Channel Strategy

        22.5.2. Novartis AG

            22.5.2.1. Indication Portfolio

            22.5.2.2. Profitability by Market Segments (Channel/Region)

            22.5.2.3. Sales Footprint

            22.5.2.4. Analyst commentary

            22.5.2.5. Strategy Overview

                22.5.2.5.1. Marketing Strategy

                22.5.2.5.2. Product Strategy

                22.5.2.5.3. Channel Strategy

        22.5.3. Ferring B.V.

            22.5.3.1. Indication Portfolio

            22.5.3.2. Profitability by Market Segments (Channel/Region)

            22.5.3.3. Sales Footprint

            22.5.3.4. Analyst commentary

            22.5.3.5. Strategy Overview

                22.5.3.5.1. Marketing Strategy

                22.5.3.5.2. Product Strategy

                22.5.3.5.3. Channel Strategy

        22.5.4. Fresenius Kabi LLC

            22.5.4.1. Indication Portfolio

            22.5.4.2. Profitability by Market Segments (Channel/Region)

            22.5.4.3. Sales Footprint

            22.5.4.4. Analyst commentary

            22.5.4.5. Strategy Overview

                22.5.4.5.1. Marketing Strategy

                22.5.4.5.2. Product Strategy

                22.5.4.5.3. Channel Strategy

        22.5.5. Hikma Pharmaceuticals PLC

            22.5.5.1. Indication Portfolio

            22.5.5.2. Profitability by Market Segments (Channel/Region)

            22.5.5.3. Sales Footprint

            22.5.5.4. Analyst commentary

            22.5.5.5. Strategy Overview

                22.5.5.5.1. Marketing Strategy

                22.5.5.5.2. Product Strategy

                22.5.5.5.3. Channel Strategy

        22.5.6. Endo International plc. (Par Sterile Products, LLC)

            22.5.6.1. Indication Portfolio

            22.5.6.2. Profitability by Market Segments (Channel/Region)

            22.5.6.3. Sales Footprint

            22.5.6.4. Analyst commentary

            22.5.6.5. Strategy Overview

                22.5.6.5.1. Marketing Strategy

                22.5.6.5.2. Product Strategy

                22.5.6.5.3. Channel Strategy

        22.5.7. Teva Pharmaceutical Industries Ltd.

            22.5.7.1. Indication Portfolio

            22.5.7.2. Profitability by Market Segments (Channel/Region)

            22.5.7.3. Sales Footprint

            22.5.7.4. Analyst commentary

            22.5.7.5. Strategy Overview

                22.5.7.5.1. Marketing Strategy

                22.5.7.5.2. Product Strategy

                22.5.7.5.3. Channel Strategy

        22.5.8. Mylan N.V.

            22.5.8.1. Indication Portfolio

            22.5.8.2. Profitability by Market Segments (Channel/Region)

            22.5.8.3. Sales Footprint

            22.5.8.4. Analyst commentary

            22.5.8.5. Strategy Overview

                22.5.8.5.1. Marketing Strategy

                22.5.8.5.2. Product Strategy

                22.5.8.5.3. Channel Strategy

        22.5.9. Wockhardt Ltd.

            22.5.9.1. Indication Portfolio

            22.5.9.2. Profitability by Market Segments (Channel/Region)

            22.5.9.3. Sales Footprint

            22.5.9.4. Analyst commentary

            22.5.9.5. Strategy Overview

                22.5.9.5.1. Marketing Strategy

                22.5.9.5.2. Product Strategy

                22.5.9.5.3. Channel Strategy

        22.5.10. Sun Pharmaceutical Industries Ltd.

            22.5.10.1. Indication Portfolio

            22.5.10.2. Profitability by Market Segments (Channel/Region)

            22.5.10.3. Sales Footprint

            22.5.10.4. Analyst commentary

            22.5.10.5. Strategy Overview

                22.5.10.5.1. Marketing Strategy

                22.5.10.5.2. Product Strategy

                22.5.10.5.3. Channel Strategy 

        22.5.11. Yuhan Corporation

            22.5.11.1. Indication Portfolio

            22.5.11.2. Profitability by Market Segments (Channel/Region)

            22.5.11.3. Sales Footprint

            22.5.11.4. Analyst commentary

            22.5.11.5. Strategy Overview

                22.5.11.5.1. Marketing Strategy

                22.5.11.5.2. Product Strategy

                22.5.11.5.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Oxytocin Market Volume (‘000 Units of 10 IU Doses) Analysis and Opportunity Assessment 2015–2030, By Region

Table 02: Global Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 03: Global Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 04: Global Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region

Table 05: North America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 06: North America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 07: North America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 08: Latin America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 09: Latin America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 10: Latin America Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 11: Europe Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 12: Europe Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 13: Europe Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 14: South Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 15: South Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 16: South Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 17: East Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 18: East Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 19: East Asia Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 20: Oceania Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 21: Oceania Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 22: Oceania Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Table 23: Middle East and Africa Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 24: Middle East and Africa Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication

Table 25: Middle East and Africa Oxytocin Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Oxytocin Pricing Analysis (US$) for Per 10 IU Dose, By Region, 2019

Figure 02: Global Oxytocin Market Volume (in 000' Units of 10 IU Doses) Analysis, 2015-2021

Figure 03: Global Oxytocin Market Volume Forecast (in 000' Units of 10 IU Doses), 2022-2030

Figure 04: Global Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 05: Global Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 06: Global Oxytocin Market Absolute $ Opportunity, 2022 - 2030

Figure 07: Global Oxytocin Market Share Analysis (%), By Indication, 2022-2030

Figure 08: Global Oxytocin Market Y-o-Y Analysis (%), By Indication, 2022-2030

Figure 09: Global Oxytocin Market Attractiveness Analysis By Indication, 2022-2030

Figure 10: Global Oxytocin Market Share Analysis (%), By Distribution Channel, 2022-2030

Figure 11: Global Oxytocin Market Y-o-Y Analysis (%), By Distribution Channel, 2022-2030

Figure 12: Global Oxytocin Market Attractiveness Analysis by Distribution Channel, 2022-2030

Figure 13: Global Oxytocin Market Share Analysis (%), By Region, 2022-2030

Figure 14: Global Oxytocin Market Y-o-Y Analysis (%), By Region, 2022-2030

Figure 15: Global Oxytocin Market Attractiveness Analysis by Region, 2022-2030

Figure 16: North America Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 17: North America Oxytocin Market Value Share, By Distribution Channel, 2022 (E)

Figure 18: North America Oxytocin Market Value Share, By Country, 2022 (E)

Figure 19: North America Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 20: North America Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 21: North America Oxytocin Market Attractiveness Analysis by Indication, 2022-2030

Figure 22: North America Oxytocin Market Attractiveness Analysis by Distribution Channel, 2022-2030

Figure 23: North America Oxytocin Market Attractiveness Analysis by Country, 2022-2030

Figure 24: Latin America Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 25: Latin America Oxytocin Market Value Share, By Distribution Channel, 2022 (E)

Figure 26: Latin America Oxytocin Market Value Share, By Country, 2022 (E)

Figure 27: Latin America Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 28: Latin America Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 29: Latin America Oxytocin Market Attractiveness Analysis by Indication, 2022-2030

Figure 30: Latin America Oxytocin Market Attractiveness Analysis by Distribution Channel, 2022-2030

Figure 31: Latin America Oxytocin Market Attractiveness Analysis by Country, 2022-2030

Figure 32: Europe Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 33: Europe Oxytocin Market Value Share, By Distribution Channel, 2022 (E)

Figure 34: Europe Oxytocin Market Value Share, By Country, 2020 (E

Figure 35: Europe Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 36: Europe Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 37: Europe Oxytocin Market Attractiveness Analysis by Indication, 2022-2030

Figure 38: Europe Oxytocin Market Attractiveness Analysis by Distribution Channel, 2022-2030

Figure 39: Europe Oxytocin Market Attractiveness Analysis by Country, 2022-2030

Figure 40: South Asia Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 41: South Asia Oxytocin Market Value Share, By Distribution Channel, 2022 (E)

Figure 42: South Asia Oxytocin Market Value Share, By Country, 2022 (E)

Figure 43: South Asia Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 44: South Asia Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 45: South Asia Oxytocin Market Attractiveness Analysis by Indication, 2022-2030

Figure 46: South Asia Oxytocin Market Attractiveness Analysis by Distribution Channel, 2022-2030

Figure 47: South Asia Oxytocin Market Attractiveness Analysis by Country, 2022-2030

Figure 48: East Asia Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 50: East Asia Oxytocin Market Value Share, By Country, 2022 (E)

Figure 51: East Asia Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 52: East Asia Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 53: East Asia Oxytocin Market Attractiveness Analysis by Indication, 2022-2030

Figure 55: East Asia Oxytocin Market Attractiveness Analysis by Country, 2022-2030

Figure 56: Oceania Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 58: Oceania Oxytocin Market Value Share, By Country, 2022 (E)

Figure 59: Oceania Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 60: Oceania Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 61: Oceania Oxytocin Market Attractiveness Analysis by Indication, 2022-2030

Figure 63: Oceania Oxytocin Market Attractiveness Analysis by Country, 2022-2030

Figure 64: Middle East and Africa Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 66: Middle East and Africa Oxytocin Market Value Share, By Country, 2022 (E)

Figure 67: Middle East and Africa Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 68: Middle East and Africa Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 69: Middle East and Africa Oxytocin Market Attractiveness Analysis by Indication, 2022-2030

Figure 70: Middle East and Africa Oxytocin Market Attractiveness Analysis by Country, 2022-2030

Figure 71: U.S. Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 72: U.S. Oxytocin Market Value Share, By Distribution Channel, 2022 (E)

Figure 73: U.S. Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 74: U.S Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 75: U.S Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 76: Canada Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 78: Canada Oxytocin Market Value Share, By Distribution Channel, 2022 (E)

Figure 79: Canada Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 80: Canada Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 81: Canada Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 82: Mexico Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 84: Mexico Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 85: Mexico Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 86: Mexico Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 87: Brazil Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 89: Brazil Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 90: Brazil Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 91: Brazil Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 92: Argentina Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 94: Argentina Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 95: Argentina Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 96: Argentina Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 97: Germany Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 99: Germany Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 100: Germany Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 101: Germany Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 102: Italy Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 104: Italy Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 105: Italy Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 106: Italy Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 107: France Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 109: France Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 110: France Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 111: France Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 112: U.K. Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 114: U.K. Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 115: U.K. Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 116: U.K. Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 117: Spain Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 119: Spain Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 120: Spain Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 121: Spain Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 122: Russia Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 124: Russia Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 125: Russia Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 126: Russia Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 127: China Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 129: China Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 130: China Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 131: China Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 132: Japan Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 134: Japan Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 135: Japan Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 136: Japan Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 137: South Korea Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 139: South Korea Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 140: South Korea Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 141: South Korea Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 142: India Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 144: India Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 145: India Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 146: India Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 147: Malaysia Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 149: Malaysia Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 150: Malaysia Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 151: Malaysia Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 152: Thailand Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 154: Thailand Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 155: Thailand Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 156: Thailand Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 157: Indonesia Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 159: Indonesia Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 160: Indonesia Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 161: Indonesia Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 162: Australia Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 164: Australia Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 165: Australia Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 166: Australia Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 167: New Zealand Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 169: New Zealand Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 170: New Zealand Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 171: New Zealand Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 172: GCC Countries Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 174: GCC Countries Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 175: GCC Countries Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 176: GCC Countries Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 177: Turkey Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 179: Turkey Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 180: Turkey Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 181: Turkey Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 182: South Africa Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 184: South Africa Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 185: South Africa Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 186: South Africa Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 187: Egypt Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 189: Egypt Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 190: Egypt Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 191: Egypt Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 192: Nigeria Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 194: Nigeria Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 195: Nigeria Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 196: Nigeria Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 197: Algeria Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 199: Algeria Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 200: Algeria Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 201: Algeria Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 202: Morroco Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 204: Morroco Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 205: Morroco Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 206: Morroco Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Figure 207: Kenya Oxytocin Market Value Share, By Indication, 2022 (E)

Figure 209: Kenya Oxytocin Market Value Analysis (US$ Mn), 2022 & 2030

Figure 210: Kenya Oxytocin Market Value Analysis (US$ Mn), 2015-2021

Figure 211: Kenya Oxytocin Market Value Forecast (US$ Mn), 2022-2030

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Femtech Market

Published : June 2021

Healthcare

Oxytocin Market

Published : December 2020

Healthcare

Oxytocic Pharmaceuticals Market

Published : July 2021

Healthcare

Fertility and Pregnancy Rapid Test Kits Market

Published : February 2022

Google translate